Trial intelligence / Profile preview

Carbetocin versus syntocinon + ergometrine for prevention of postpartum haemorrhage during elective caesarean section

2007-002341-20Phase 4Completed

Sponsor
Queen Charlotte's and Chelsea Hospital
Start
May 2008
Modality
Peptides, Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in postpartum hemorrhage (PPH) comparing Carbetocin with Syntocinon + ergometrine (2 arms). Started May 2008; status: completed.

02

Drugs

carbetocinoxytocinergonovine maleate
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on 2007-002341-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002341-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call